Tag: Saetbyeol-9
No posts to display
Top News
Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive...
Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.
- Our Sponsors Ad -